![](https://www.Immune-System-Research.com/"wp-content/uploads"/2022/02/Blebbistatin-is-a-Selective-Non-Muscle-Myosin-II-NMII-Inhibitor-2022-02-16_画板-1-1600x914.jpg)
Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor, promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing,…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2022/01/Fasiglifam-is-a-Selective-and-Orally-Active-GPR40-Agonist-2022-02-07-1600x914.png)
Fasiglifam (TAK-875) acts as a novel, orally available, selective GPR40 agonist. TAK-875 (0.01-10 μM) produces a concentration-dependent increase in intracellular…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2022/01/Licogliflozin-is-a-dual-SGLT1-and-SGLT2-Inhibitor-2022-01-18.jpg)
In general, obesity more greatly contributes to the global burden of disease (also associated with co-morbidities) in recent years .…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/12/NCATS-SM4487-is-a-Selective-Unique-Dihydropyrimidine-Inhibitor-Against-GALK1-2021-12-20.jpg)
Galactosemia is a rare genetic metabolic disorder that affects an individual’s ability to metabolize the sugar galactose properly. And it…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/11/Dynasore-is-a-Cell-Permeable-Dynamin-Inhibitor-11-18.jpg)
Dynamins are large superfamily GTPase proteins that are involved in various cellular processes including budding of transport vesicles, division of…